Using state of the art methodologies within cloning, virus variant production and sequencing, rAAVen builds novel viral vectors for precision targeting of defined cell populations or with desired properties.
rAAVen Therapeutics
rAAVen Therapeutics is driven by curiosity and dedication. The company has the expertise and commitment to generate novel AAV capsids that can be used to tackle a wide array of disorders.
